| CAS NO: | 162641-16-9 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| 生物活性 | HQL-79, a potent, selective and orally active humanhematopoietic prostaglandin D synthase (H-PGDS)inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with aKdof 0.8 μM and anIC50of 6 μM. Shows no obvious effect onCOX-1,COX-2, m-PGES, or L-PGDS[1]. | ||||||||||||
| IC50& Target | IC50: 6 μM (H-PGDS)[1] | ||||||||||||
| 体外研究 (In Vitro) | HQL-79 is a competitive inhibitor against substrate PGH2 and a non-competitive one against GSH[1]. | ||||||||||||
| 分子量 | 377.48 | ||||||||||||
| 性状 | Solid | ||||||||||||
| Formula | C22H27N5O | ||||||||||||
| CAS 号 | 162641-16-9 | ||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| 储存方式 |
|
m.cnreagent.com